| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |